Dr. Giuseppe Mazza, PhD

Co-Founder and CEO at Engitix Therapeutics

Speaker

Co-founder and CEO of Engitix, established in 2016 to translate research from University College London (UCL) into a proprietary human extracellular matrix (ECM) drug discovery platform. Has led the company through rapid growth, multiple funding rounds, and strategic partnerships with Dompé, Takeda, and Morphic, while building state-of-the-art laboratories in White City, London. Holds a PhD in Tissue Engineering and Organ Regeneration from UCL and serves as an Honorary Associate Professor. Previously served as Director of R&D at Promethera Bioscience and held leadership roles across several healthcare organisations, including founding the charity Associazione Icore ONLUS.